Loading…
Remote · PA · United States
Research provider: Pitt+Me
Have you been diagnosed with type 1 diabetes for at least 5 years? You may be eligible for a research study to assess the effect, safety and tolerability of an experimental study drug. This study will involve about 6 study visits and 2 phone calls and will take approximately 16 weeks to complete. Compensation is provided.
The study consists of a Screening Period (4 or 8 weeks): During this time, participants will be evaluated to see if they qualify to join the study. Study Treatment Period 1 (4 weeks): Participants will be randomly assigned to receive either the study drug or a placebo (an inactive injection that looks like the study drug but has no effect). Washout Period 1 (about 14 days): Participants will stop taking any study medication to allow the drug to completely leave their system. Study Treatment Period 2 (4 weeks): Participants who initially received the study drug will now receive the placebo, and those who initially received the placebo will now receive the study drug. Washout Period 2 (about 14 days): Again, participants will stop taking any study medication to ensure the drug is fully cleared from their body. Final Study Visit: Participants will return to the study site for a final check-up and assessment.
Have you been diagnosed with type 1 diabetes for at least 5 years? You may be eligible for a research study to assess the effect, safety and tolerability of an experimental study drug. This study will involve about 6 study visits and 2 phone calls and will take approximately 16 weeks to complete. Compensation is provided.
Review the provider’s screening questions. These requirements do not guarantee selection.